News
Dementia Discovery Fund Chooses Alector for First Investment
LONDON—A promising new avenue in Alzheimer’s research that focuses on the eradication of [...]
Alector Announces $29.5M Series D Financing
Alector LLC, a biotech company pioneering the discovery and development of first-in-class [...]
4D Molecular Therapeutics Announces Collaboration With Pfizer, Inc.
for Cardiac Gene Therapy Vector Discovery and Development 4D Molecular Therapeutics (4DMT [...]
Fay Christodoulou, CSO, Miroculus
The notion of small molecules that detect dozens of cancers may sound like something out o [...]
David Whitlock of AOBiome | Q&A
Chemical engineer David Whitlock has made a splash in the media as of late, due to his la [...]
How Bell Biosystems is using naturally magnetic bacteria to track cell therapies
With FDA calling for non-invasive new tracking systems to accompany cell therapies, Bell B [...]
Amarantus Announces Issuance of Australian Patent
Covering Eltoprazine Treatment of Parkinson’s Disease and Alzheimer’s Disease Amarantus B [...]
Blueprint Genetics Plans to Boost Inherited Disease Panel Portfolio Next Year
Finnish hereditary disease diagnostics firm Blueprint Genetics plans to significantly expa [...]
Symic Biomedical Selects Osteoarthritis Clinical Candidate
Symic Biomedical, a clinical-stage biotherapeutics company developing multiple compounds t [...]
A guy who hasn’t showered in 12 years just helped launch a skin care company
Forgoing a shower, even for a day, makes some people want to hide from society and double [...]
A new dawn for cataracts
On Thursday, November 6, scientists from ViewPoint Therapeutics published an article title [...]
Symic Biomedical Advances First Product Candidate, SB-030, Into Clinical Development
Symic Biomedical, a clinical-stage biotherapeutics platform company developing compounds t [...]
Amarantus seeks US FDA orphan drug status for eltoprazine
Amarantus Bioscience Holdings, Inc., a biotechnology company, has submitted a request to [...]
Military researchers to conduct trial of Amarantus’s “engineered skin substitute”
Cooperative research and development efforts with the military, universities and the biote [...]
Now You Can Buy Shampoo and Cleanser That Promote the Growth of “Good” Bacteria
If you’ve heard about probiotic cosmetic spray, it’s probably from a New York Times Magazi [...]
AOBiome Announces Start of First Clinical Trial with Ammonia Oxidizing Bacteria-Based Therapeutic for Treatment of Acne
AOBiome today announced it has begun a Phase 2 clinical trial with a therapeutic product [...]
Robots And Microbes: Zymergen Raises $44 Million From Big VCs
The two biology experts–one a biophysicist, one a biochemist–were studying microbes, the s [...]
Golden Helix integrates MedGenome’s OncoMD into its VarSeq software
Golden Helix Inc., a leading bioinformatics solutions provider, has now announced the int [...]
AOBiome Announces Three Senior Management Appointments
AOBiome today announced three appointments to its senior management team to advance the c [...]
Ethan Perlstein featured in CNET story on “science labs in the cloud”
Science is hard. Repeating other labs' findings is even harder. That's particularly true i [...]
Amarantus Releases Preliminary Data From Blood-Based MS Diagnostic
Amarantus BioScience has released preliminary data from a blood test for multiple sclerosi [...]
Rich Yu talks about how incubator saving water during CA drought
Richard Yu, Ph.D., scientific and operations director for the QB3@953 incubator in San Fra [...]
SolveBio, MedGenome Ink Data Distribution Agreement
Today, SolveBio, a provider of data infrastructure for genomics, announced a partnership w [...]